Abstract
Gorham-Stout disease is a rare bone resorption disease, the etiology and prognosis of which is uncertain but it is thought to be benign. It can involve one or more bones and can cause pain, swelling, deformity and fractures in affected bones. Diagnosis is made with a combination of clinical, radiological and histopathological examinations once other causes of osteolysis have been excluded. Due to its rarity, there is no standard therapeutic approach.
Zusammenfassung
Das Gorham-Stout-Syndrom ist eine seltene Erkrankung, bei der es zu einem Knochenabbau kommt. Ätiologie und Prognose sind ungewiss, aber es gilt als benigne. Es kann ein oder mehrere Knochen betreffen, dabei kann es zu Schmerzen, Schwellungen, Deformitäten und Frakturen in den betroffenen Knochen kommen. Die Diagnose wird anhand einer Kombination aus klinischen, radiologischen und histopathologischen Untersuchungen gestellt, sofern andere Ursachen für die Osteolyse ausgeschlossen wurden. Aufgrund seiner Seltenheit gibt es keine Standardtherapie für diese Erkrankung.
Abbreviations
- ALP:
-
Alkaline phosphatase
- AP:
-
Anteroposterior
- CT:
-
Computed tomography
- GSD:
-
Gorham-Stout disease
- MM:
-
Multiple myeloma
- PET-CT:
-
Positron emission tomography-CT
- PTH:
-
Parathyroid hormone
- VEGF:
-
Vascular endothelial growth factor
- ZA:
-
Zoledronic acid
References
Heritier S, Donadieu J (2012) Gorham’s disease and intra-osseous vascular abnormalities. Bull Cancer 99(5):599–604
Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37(5):985–1004
Tolis K, Triantafyllopoulos IK, Tournis S, Papaioannou NA (2016) Gorham-Stout disease of the pelvis: Seven years follow up with complete radiological evaluation. J Musculoskelet Neuronal Interact 16(1):79–82
Sahoo RK, Jagannathan B, Palanichamy G, Natarajan V (2012) Anaesthetic consideration in patients with Gorham’s syndrome: a case report and review of the literature. Indian J Anaesth 56(4):391–393
Yoo SY, Hong SH, Chung HW, Choi JA, Kim CJ, Kang HS (2002) MRI of Gorham’s disease: findings in two cases. Skeletal Radiol 31(5):301–306
Mawk JR, Obukhov SK, Nichols WD, Wynne TD, Odell JM, Urman SM (1997) Successful conservative management of Gorham disease of the skull base and cervical spine. Childs Nerv Syst 13(11–12):622–625
Patel DV (2005) Gorham’s disease or massive osteolysis. Clin Med Res 3:65–74
Angelini A, Mavrogenis AF, Rimondi E, Rossi G, Ruggieri P (2017) Current concepts for the diagnosis and management of eosinophilic granuloma of bone. J Orthop Traumatol 18:83–90
Mollee P (2009) Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathies. Clin Biochem Rev 30(3):93–103
Nikolaou VS, Chytas D, Korres D, Efstathopoulos N (2014) Vanishing bone disease (Gorham-Stout syndrome): a review of a rare entity. World J Orthop 5(5):694–698
Yerganyan VV, Body JJ, De Saint Aubain N, Gebhart M (2015) Gorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid. J Bone Oncol 4(2):42–46
Lehmann G, Pfeil A, Bottcher J et al (2009) Benefit of a 17-year long-term bisphosphonate therapy in a patient with GorhamStout syndrome. Arch Orthop Trauma Surg 129:967–972
Hammer F, Kenn W, Wesselmann U et al (2005) Gorham-Stout disease—stabilization during bisphosphonate treatment. J Bone Miner Res 20:350–353
Stefanidou M, Ioannidou D, Panayotides J et al (2004) Cutaneous vascular malformation associated with osteolysis or Gorham’s sign. Int J Dermatol 43:958–961
Avelar RL, Martins VB, Antunes AA, de Oliveira Neto PJ, Andrade ES (2010) Use of zoledronic acid in the treatment of Gorham’s disease. Int J Pediatr Otorhinolaryngol 74(3):319–322
Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R (2005) Treatment of Gorham’s disease with zoledronic acid. Oral Oncol 41:747–750
Kuriyama DK, McElligott SC, Glaser DW, Thompson KS (2010) Treatment of Gorham-Stout disease with zoledronic acid and interferon-α: a case report and literature review. J Pediatr Hematol Oncol 32(8):579–584
Cramer SL, Wei S, Merrow AC, Pressey JG (2016) Gorham-stout disease successfully treated with Sirolimus and Zoledronic acid therapy. J Pediatr Hematol Oncol 38(3):e129–e132
Ocarino NM, Serakides R (2006) Effect of the physical activity on normal bone and on the osteoporosis prevention and treatment. Rev Bras Med Esporte 12(3):149–152
Ellati R, Attili A, Haddad H, Al-Hussaini M, Shehadeh A (2016) Novel approach of treating Gorham-Stout disease in the humerus—Case report and review of literature. Eur Rev Med Pharmacol Sci 20(3):426–432
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
O.G. Illeez, K. Ozkan, F.U. Ozkan, A.B. Bostan, F. Akpinar, B. Bilgic and I. Aktas declare that they have no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors. For images or other information within the manuscript which identify patients, consent was obtained from them and/or their legal guardians.
Rights and permissions
About this article
Cite this article
Illeez, O.G., Ozkan, K., Ozkan, F.U. et al. Zoledronic acid. Orthopäde 47, 1032–1035 (2018). https://doi.org/10.1007/s00132-018-3655-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00132-018-3655-z